Tenascin-C
Tenascin
is a
large extracellular matrix glycoprotein expressed in fibroblasts and
in the extracellular matrix during embryogenesis and growth. It has a
unique six-armed multidomain macromolecular structure. Repetitive
sequences resembling epidermal growth factor indicate that it may
bind to epidermal growth factor receptor12.
Immunohistochemical expression
-
Skin: sparsely at the dermo-epidermal junction, by the papillary
dermis and around adnexa. Expression is increased in wound healing1.
-
Hyperplastic breast lesions and breast carcinoma2,3,4
-
Colonic carcinomas5
-
Squamous cell carcinomas of the oral cavity6,7
and skin8
-
Lung carcinomas8
-
Schwannomas10
-
Leiomyosarcomas10
-
Fibromas10
-
Liposarcomas10
-
Cutaneous fibrohistiocytic tumours11
-
Diagnostic utility
-
There is increased expression at the dermo-epidermal junction
overlying dermatofibromas but
not dermatofibrosarcoma protuberans1.
-
Expression is
more common in malignant than benign phaeochromocytomas and paragangliomas12.
The staining is of the stroma
around tumour cells:
|
negative (less
than 5% cells staining) |
weak (6 to 25%
of cells staining) |
moderate (26
to 50% of cells staining) |
strong (more
than 50% of cells staining) |
|
phaeochromocytoma |
benign |
14/37 |
12/47 |
4/47 |
7/47 |
borderline
(capsular or vascular invasion, confluent tumour necrosis or >5
mitoses / 10 HPF) |
6/28 |
9/28 |
11/28 |
2/28 |
malignant
(defined as metastasising or widespread local invasion) |
0/3 |
0/3 |
1/3 |
2/3 |
paraganglioma |
benign |
1/23 |
11/23 |
6/23 |
5/23 |
borderline
(capsular or vascular invasion, confluent tumour necrosis or >5
mitoses / 10 HPF) |
1/8 |
3/8 |
2/8 |
2/8 |
malignant
(defined as metastasising or widespread local invasion) |
0/4 |
2/4 |
0/4 |
2/4 |
the normal adrenal medulla is negative, although focal staining may
be seen around adrenocortical cells. |
References
1Kahn,
H. J., Fekete, E., From, L. Tenascin differentiates dermatofibroma
from dermatofibrosarcoma protuberans: comparison with CD34 and factor
XIIIa. Hum Pathol 2001;32:50-56.
2Ishihara,
A., Yoshida, T., Tamaki, H., Sakakura, T. Tenascin expression in
cancer cells and stroma of human breast cancer and its prognostic
significance. Clin Cancer Res 1995;9:1035-1041.
3Tokes,
A. M., Hortovanyi, E., Csordas, G., Kulka, J., Mozes, G., Hatalyak,
A., Kadar, A. Immunohistochemical localisation of tenascin in
invasive ductal carcinoma of the breast. Anticancer Res 1999;19:175-179
4Howeedy,
A. A., Virtanen, I., Laitinen, L., Gould, N. S., Koukoulis, G. K.,
Gould, V. E. Differential distribution of tenascin in the normal,
hyperplastic, and neoplastic breast. Lab Invest 1990;63:798-806
5Iskaros,
B. F., Tanaka, K. E., Hu, X., Kadish, A. S., Steinberg, J. J.
Morphologic pattern of tenascin as a diagnostic biomarker in colon
cancer. J Surg Oncol 1997;64:98-101.
6Mori,
M., Muramatsu, Y., Yamada, K., Shrestha, P., Takai, Y. Intracellular
localization of tenascin in squamous cell carcinoma of oral cavity:
an immunohistochemical study. Anticancer Res 1996;16:3075-3079.
7Ramos,
D. M., Chen, B., Regezi, J., Zardi, L., Pytela, R. Tenascin-C matrix
assembly in oral squamous cell carcinoma. Int J Cancer 1998;75:680-687.
8Koukoulis,
G. K., Gould, V. E., Bhattacharyya, A., Gould, J. E., Howeedy, A.
A., Virtanen, I. Tenascin in normal, reactive, hyperplastic, and
neoplastic tissues: biologic and pathologic implications. Human
Pathol 1991;22:636-643
9Erickson,
H. P., Bourdon, M. A. Tenascin: an extracellular matrix protein
prominent in specialized embryonic tissues and tumors. Ann Rev Cell
Biol 1989;5:71
10Schnyder,
B., Semadeni, R. O., Fischer, R. W., Vaughan, L., Car, B. D., Heitz,
P. U., Winterhalter, K. H., Odermatt, B. Distribution pattern of
tenascin-C in normal and neoplastic mesenchymal tissues. Int J Cancer 1997;72:217-224.
11Franchi,
A., Santucci, M. Tenascin expression in cutaneous fibrohistiocytic
tumors. Immunohistochemical investigation of 24 cases. Am J
Dermatopathol 1996;18:454-459.
12Salmenkivi,
K., Haglund, C., Arola, J., Heikkila, P. Increased expression of
tenascin in pheochromocytomas correlates with malignancy. Am J Surg
Pathol 2001;25:1419-23.
13Anagnostopoulos,
I., Schuppan, D., Riecken, E. O., Gross, U. M., Stein, H. Tenascin
labelling in colorectal biopsies: a useful marker in the diagnosis of
collagenous colitis. Histopathology 1999;34:425-31.
This page last
revised 5.11.2001.
©SMUHT/PW Bishop